The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease

NCT01749059 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6147

Last updated 2016-12-19

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of implementing a universal pulse oximeter screening as a way to detect critical congenital heart disease in otherwise well-appearing newborns.

Conditions

  • Congenital Heart Disease

Sponsors & Collaborators

  • Pediatrix

    lead OTHER

Principal Investigators

  • Reese H Clark, MD · Pediatrix

Eligibility

Max Age
30 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01749059 on ClinicalTrials.gov